{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:17:09Z","timestamp":1791818229318,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173041"],"award-info":[{"award-number":["82173041"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-13253-y","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T10:21:01Z","timestamp":1733221261000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["FTO-mediated demethylation of MTUS1\/ATIP1 promotes tumor progression in head and neck squamous cell carcinoma"],"prefix":"10.1186","volume":"24","author":[{"given":"Dongxiao","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congyuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anxun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"key":"13253_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12943-015-0348-7","volume":"14","author":"C-H Chen","year":"2015","unstructured":"Chen C-H, Chang AYW, Li S-H, Tsai H-T, Shiu L-Y, Su L-J, et al. Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer. Mol Cancer. 2015;14:83.","journal-title":"Mol Cancer"},{"key":"13253_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"13253_CR3","doi-asserted-by":"publisher","first-page":"102088","DOI":"10.1016\/j.ctrv.2020.102088","volume":"90","author":"L Attademo","year":"2020","unstructured":"Attademo L, Tuninetti V, Pisano C, Cecere SC, Di Napoli M, Tambaro R, et al. Immunotherapy in cervix cancer. Cancer Treat Rev. 2020;90:102088.","journal-title":"Cancer Treat Rev"},{"key":"13253_CR4","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1096\/fj.02-0934fje","volume":"17","author":"S Seibold","year":"2003","unstructured":"Seibold S, Rudroff C, Weber M, Galle J, Wanner C, Marx M. Identification of a new tumor suppressor gene located at chromosome 8p21.3-22. FASEB J. 2003;17:1180\u20132.","journal-title":"FASEB J"},{"key":"13253_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.molonc.2011.11.002","volume":"6","author":"X Ding","year":"2012","unstructured":"Ding X, Zhang N, Cai Y, Li S, Zheng C, Jin Y, et al. Down-regulation of tumor suppressor MTUS1\/ATIP is associated with enhanced proliferation, poor differentiation and poor prognosis in oral tongue squamous cell carcinoma. Mol Oncol. 2012;6:73\u201380.","journal-title":"Mol Oncol"},{"key":"13253_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.gene.2006.05.021","volume":"380 2","author":"MD Benedetto","year":"2006","unstructured":"Benedetto MD, Bi\u00e8che I, Deshayes F, Vacher S, Nouet S, Collura V, et al. Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIP. Gene. 2006;380 2:127\u201336.","journal-title":"Gene"},{"key":"13253_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12885-015-1209-x","volume":"15","author":"T Zhao","year":"2015","unstructured":"Zhao T, Ding X, Chang B, Zhou X, Wang A. MTUS1\/ATIP3a down-regulation is associated with enhanced migration, invasion and poor prognosis in salivary adenoid cystic carcinoma. BMC Cancer. 2015;15:203.","journal-title":"BMC Cancer"},{"key":"13253_CR8","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3892\/ol.2015.3898","volume":"11 1","author":"T Zhao","year":"2016","unstructured":"Zhao T, He Q, Liu Z, Ding X, Zhou X, Wang A, Angiotensin. II type 2 receptor-interacting protein 3a suppresses proliferation, migration and invasion in tongue squamous cell carcinoma via the extracellular signal-regulated kinase-Snai2 pathway. Oncol Lett. 2016;11 1:340\u20134.","journal-title":"Oncol Lett"},{"key":"13253_CR9","doi-asserted-by":"crossref","unstructured":"Tang D, Zhao L, Huang S, Li W, He Q, Wang A. Mitochondrial outer membrane protein MTUS1\/ATIP1 exerts antitumor effects through ROS-induced mitochondrial pyroptosis in head and neck squamous cell carcinoma. Int J Biol Sci. 2024;20.","DOI":"10.7150\/ijbs.94795"},{"key":"13253_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","volume":"21","author":"Y An","year":"2022","unstructured":"An Y, Duan H. The role of m6A RNA methylation in cancer metabolism. Mol Cancer. 2022;21:14.","journal-title":"Mol Cancer"},{"key":"13253_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12943-019-1109-9","volume":"18","author":"L He","year":"2019","unstructured":"He L, Li H, Wu A, Peng Y, Shu G, Yin G. Functions of N6-methyladenosine and its role in cancer. Mol Cancer. 2019;18:176.","journal-title":"Mol Cancer"},{"key":"13253_CR12","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1158\/0008-5472.CAN-18-2965","volume":"79","author":"Q Lan","year":"2019","unstructured":"Lan Q, Liu PY, Haase J, Bell JL, H\u00fcttelmaier S, Liu T. The critical role of RNA m6A methylation in Cancer. Cancer Res. 2019;79:1285\u201392.","journal-title":"Cancer Res"},{"key":"13253_CR13","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature23450","volume":"548","author":"H-B Li","year":"2017","unstructured":"Li H-B, Tong J, Zhu S, Batista PJ, Duffy EE, Zhao J, et al. m6A mRNA methylation controls T cell homeostasis by targeting the IL-7\/STAT5\/SOCS pathways. Nature. 2017;548:338\u201342.","journal-title":"Nature"},{"key":"13253_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","volume":"22","author":"H Weng","year":"2018","unstructured":"Weng H, Huang H, Wu H, Qin X, Zhao BS, Dong L, et al. METTL14 inhibits hematopoietic Stem\/Progenitor differentiation and promotes Leukemogenesis via mRNA m6A modification. Cell Stem Cell. 2018;22:191\u2013e2059.","journal-title":"Cell Stem Cell"},{"key":"13253_CR15","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nchembio.687","volume":"7","author":"G Jia","year":"2011","unstructured":"Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7:885\u20137.","journal-title":"Nat Chem Biol"},{"key":"13253_CR16","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/mc.22782","volume":"57","author":"S Zhou","year":"2018","unstructured":"Zhou S, Bai Z-L, Xia D, Zhao Z-J, Zhao R, Wang Y-Y, et al. FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting \u03b2-catenin through mRNA demethylation. Mol Carcinog. 2018;57:590\u20137.","journal-title":"Mol Carcinog"},{"key":"13253_CR17","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1080\/15476286.2020.1841458","volume":"18","author":"L Zhang","year":"2021","unstructured":"Zhang L, Wan Y, Zhang Z, Jiang Y, Lang J, Cheng W, et al. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway. RNA Biol. 2021;18:1265\u201378.","journal-title":"RNA Biol"},{"key":"13253_CR18","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41416-021-01581-w","volume":"126","author":"T Shimura","year":"2022","unstructured":"Shimura T, Kandimalla R, Okugawa Y, Ohi M, Toiyama Y, He C, et al. Novel evidence for m6A methylation regulators as prognostic biomarkers and FTO as a potential therapeutic target in gastric cancer. Br J Cancer. 2022;126:228\u201337.","journal-title":"Br J Cancer"},{"key":"13253_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","volume":"31","author":"Z Li","year":"2017","unstructured":"Li Z, Weng H, Su R, Weng X, Zuo Z, Li C, et al. FTO plays an oncogenic role in Acute myeloid leukemia as a N6-Methyladenosine RNA demethylase. Cancer Cell. 2017;31:127\u201341.","journal-title":"Cancer Cell"},{"key":"13253_CR20","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.trecan.2022.02.010","volume":"8","author":"Y Li","year":"2022","unstructured":"Li Y, Su R, Deng X, Chen Y, Chen J. FTO in cancer: functions, molecular mechanisms, and therapeutic implications. Trends Cancer. 2022;8:598\u2013614.","journal-title":"Trends Cancer"},{"key":"13253_CR21","doi-asserted-by":"publisher","first-page":"17022","DOI":"10.18632\/aging.103622","volume":"12","author":"H Shi","year":"2020","unstructured":"Shi H, Zhao J, Han L, Xu M, Wang K, Shi J, et al. Retrospective study of gene signatures and prognostic value of m6A regulatory factor in non-small cell lung cancer using TCGA database and the verification of FTO. Aging. 2020;12:17022\u201337.","journal-title":"Aging"},{"key":"13253_CR22","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s13046-020-01731-7","volume":"39","author":"C Yue","year":"2020","unstructured":"Yue C, Chen J, Li Z, Li L, Chen J, Guo Y. microRNA-96 promotes occurrence and progression of colorectal cancer via regulation of the AMPK\u03b12-FTO-m6A\/MYC axis. J Exp Clin Cancer Res. 2020;39:240.","journal-title":"J Exp Clin Cancer Res"},{"key":"13253_CR23","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1016\/j.ymthe.2020.06.024","volume":"28","author":"L Liu","year":"2020","unstructured":"Liu L, Wu Y, Li Q, Liang J, He Q, Zhao L, et al. METTL3 promotes tumorigenesis and metastasis through BMI1 m6A methylation in oral squamous cell carcinoma. Mol Ther. 2020;28:2177\u201390.","journal-title":"Mol Ther"},{"key":"13253_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12935-022-02715-7","volume":"22","author":"J Chen","year":"2022","unstructured":"Chen J, Li S, Huang Z, Cao C, Wang A, He Q. METTL3 suppresses anlotinib sensitivity by regulating m6A modification of FGFR3 in oral squamous cell carcinoma. Cancer Cell Int. 2022;22:295.","journal-title":"Cancer Cell Int"},{"key":"13253_CR25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/nprot.2012.148","volume":"8","author":"D Dominissini","year":"2013","unstructured":"Dominissini D, Moshitch-Moshkovitz S, Salmon-Divon M, Amariglio N, Rechavi G. Transcriptome-wide mapping of N(6)-methyladenosine by m(6)A-seq based on immunocapturing and massively parallel sequencing. Nat Protoc. 2013;8:176\u201389.","journal-title":"Nat Protoc"},{"key":"13253_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S1470-2045(11)70318-7","volume":"13","author":"R Pirker","year":"2012","unstructured":"Pirker R, Pereira JR, von Pawel J, Krzakowski M, Ramlau R, Park K, et al. EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study. Lancet Oncol. 2012;13:33\u201342.","journal-title":"Lancet Oncol"},{"key":"13253_CR27","doi-asserted-by":"crossref","unstructured":"Esposito AM, Mateyak M, He D, Lewis M, Sasikumar AN, Hutton J et al. Eukaryotic polyribosome profile analysis. J Vis Exp. 2010;:1948.","DOI":"10.3791\/1948-v"},{"key":"13253_CR28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/cac2.12273","volume":"42","author":"J Chen","year":"2022","unstructured":"Chen J, Li K, Chen J, Wang X, Ling R, Cheng M, et al. Aberrant translation regulated by METTL1\/WDR4-mediated tRNA N7-methylguanosine modification drives head and neck squamous cell carcinoma progression. Cancer Commun (Lond). 2022;42:223\u201344.","journal-title":"Cancer Commun (Lond)"},{"key":"13253_CR29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1523\/JNEUROSCI.1211-20.2020","volume":"41","author":"NH Tu","year":"2021","unstructured":"Tu NH, Jensen DD, Anderson BM, Chen E, Jimenez-Vargas NN, Scheff NN, et al. Legumain induces oral Cancer Pain by Biased Agonism of protease-activated Receptor-2. J Neurosci. 2021;41:193\u2013210.","journal-title":"J Neurosci"},{"key":"13253_CR30","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4149\/neo_2014_018","volume":"61","author":"X Li","year":"2014","unstructured":"Li X, Liu H, Yu T, Dong Z, Tang L, Sun X. Loss of MTUS1 in gastric cancer promotes tumor growth and metastasis. Neoplasma. 2014;61:128\u201335.","journal-title":"Neoplasma"},{"key":"13253_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.gene.2015.04.065","volume":"567","author":"M Kara","year":"2015","unstructured":"Kara M, Yumrutas O, Ozcan O, Celik OI, Bozgeyik E, Bozgeyik I, et al. Differential expressions of cancer-associated genes and their regulatory miRNAs in colorectal carcinoma. Gene. 2015;567:81\u20136.","journal-title":"Gene"},{"key":"13253_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.gene.2016.05.006","volume":"587","author":"M Kara","year":"2016","unstructured":"Kara M, Kaplan M, Bozgeyik I, Ozcan O, Celik OI, Bozgeyik E, et al. MTUS1 tumor suppressor and its miRNA regulators in fibroadenoma and breast cancer. Gene. 2016;587:173\u20137.","journal-title":"Gene"},{"key":"13253_CR33","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3390\/cancers13061245","volume":"13","author":"N Ranjan","year":"2021","unstructured":"Ranjan N, Pandey V, Panigrahi MK, Klumpp L, Naumann U, Babu PP. The tumor suppressor MTUS1\/ATIP1 Modulates Tumor Promotion in Glioma: Association with epigenetics and DNA repair. Cancers (Basel). 2021;13:1245.","journal-title":"Cancers (Basel)"},{"key":"13253_CR34","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3892\/ol.2015.3898","volume":"11","author":"T Zhao","year":"2016","unstructured":"Zhao T, He Q, Liu Z, Ding X, Zhou X, Wang A, Angiotensin. II type 2 receptor-interacting protein 3a suppresses proliferation, migration and invasion in tongue squamous cell carcinoma via the extracellular signal-regulated kinase-Snai2 pathway. Oncol Lett. 2016;11:340\u20134.","journal-title":"Oncol Lett"},{"key":"13253_CR35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature11112","volume":"485","author":"D Dominissini","year":"2012","unstructured":"Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012;485:201\u20136.","journal-title":"Nature"},{"key":"13253_CR36","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.apsb.2018.06.001","volume":"8","author":"Y Niu","year":"2018","unstructured":"Niu Y, Wan A, Lin Z, Lu X, Wan G. N 6-Methyladenosine modification: a novel pharmacological target for anti-cancer drug development. Acta Pharm Sin B. 2018;8:833\u201343.","journal-title":"Acta Pharm Sin B"},{"key":"13253_CR37","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1126\/science.1261417","volume":"347","author":"S Geula","year":"2015","unstructured":"Geula S, Moshitch-Moshkovitz S, Dominissini D, Mansour AA, Kol N, Salmon-Divon M, et al. m6A mRNA methylation facilitates resolution of naive pluripotency toward differentiation. Science. 2015;347:1002\u20136.","journal-title":"Science"},{"key":"13253_CR38","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1038\/s41467-019-10669-0","volume":"10","author":"S Yang","year":"2019","unstructured":"Yang S, Wei J, Cui Y-H, Park G, Shah P, Deng Y, et al. m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade. Nat Commun. 2019;10:2782.","journal-title":"Nat Commun"},{"key":"13253_CR39","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s43018-021-00223-7","volume":"2","author":"J Jeschke","year":"2021","unstructured":"Jeschke J, Collignon E, Al Wardi C, Krayem M, Bizet M, Jia Y, et al. Downregulation of the FTO m6A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to wnt inhibitors. Nat Cancer. 2021;2:611\u201328.","journal-title":"Nat Cancer"},{"key":"13253_CR40","doi-asserted-by":"publisher","first-page":"16339","DOI":"10.3390\/ijms242216339","volume":"24","author":"Z Wang","year":"2023","unstructured":"Wang Z, Li H, Cai H, Liang J, Jiang Y, Song F, et al. FTO sensitizes oral squamous cell carcinoma to ferroptosis via suppressing ACSL3 and GPX4. Int J Mol Sci. 2023;24:16339.","journal-title":"Int J Mol Sci"},{"key":"13253_CR41","doi-asserted-by":"publisher","first-page":"6402","DOI":"10.1002\/cam4.4188","volume":"10","author":"X Li","year":"2021","unstructured":"Li X, Xie X, Gu Y, Zhang J, Song J, Cheng X, et al. Fat mass and obesity-associated protein regulates tumorigenesis of arecoline-promoted human oral carcinoma. Cancer Med. 2021;10:6402\u201315.","journal-title":"Cancer Med"},{"key":"13253_CR42","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12935-019-1045-1","volume":"19","author":"D Zou","year":"2019","unstructured":"Zou D, Dong L, Li C, Yin Z, Rao S, Zhou Q. The m6A eraser FTO facilitates proliferation and migration of human cervical cancer cells. Cancer Cell Int. 2019;19:321.","journal-title":"Cancer Cell Int"},{"key":"13253_CR43","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.bbrc.2019.03.093","volume":"512","author":"J Li","year":"2019","unstructured":"Li J, Han Y, Zhang H, Qian Z, Jia W, Gao Y, et al. The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA. Biochem Biophys Res Commun. 2019;512:479\u201385.","journal-title":"Biochem Biophys Res Commun"},{"key":"13253_CR44","doi-asserted-by":"crossref","unstructured":"Shan H-J, Gu W-X, Duan G, Chen H-L. Fat mass and obesity associated (FTO)-mediated N6-methyladenosine modification of Kr\u00fcppel-like factor 3 (KLF3) promotes osteosarcoma progression. Bioengineered 13:8038\u201350.","DOI":"10.1080\/21655979.2022.2051785"},{"key":"13253_CR45","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12943-019-1004-4","volume":"18","author":"Y Niu","year":"2019","unstructured":"Niu Y, Lin Z, Wan A, Chen H, Liang H, Sun L, et al. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Mol Cancer. 2019;18:46.","journal-title":"Mol Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13253-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-13253-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13253-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T11:04:48Z","timestamp":1733223888000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-13253-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["13253"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-13253-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]},"assertion":[{"value":"8 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the First Affiliated Hospital of Sun Yat-Sen University approved the animal experiments ([2022]229). All samples were obtained with informed consent and the use was approved by the Institutional Review Board of the First Affiliated Hospital of Sun Yat-Sen University ([2016]074 and [2022]229).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1489"}}